WuXi XDC Cayman stock

2268 · HKEX · HKD

Compare WuXi XDC Cayman
$59.70Change from previous close: −5.61%Absolute change: −$3.55

Close · November 20, 2026

Price history

−13.60% over the period

1 year: from $69.10 (November 20, 2025) to $59.70 (November 20, 2026), −13.60%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$59.70
October 30, 2026$66.65
September 30, 2026$82.00
August 31, 2026$69.95
July 31, 2026$51.80
June 30, 2026$57.05
May 29, 2026$54.90
April 30, 2026$58.90
March 31, 2026$58.20
February 27, 2026$63.15
January 30, 2026$62.80
December 31, 2025$60.70
November 28, 2025$65.45
November 20, 2025$69.10

At a glance

  • The company

    Contract research, development and manufacturing organization specializing in antibody drug conjugates and related bioconjugate therapies

  • Latest results

    Quarter to June 30, 2025 · EPS ¥0.57 (estimate ¥0.54)

TickerLandia's take on WuXi XDC Cayman

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$43.50
52-wk high$85.60

−30.26% from the 52-week high

Analysts · 21 analysts

Average target$92.94+55.68% vs. price

Buy 21 · Hold 0 · Sell 0 · Strong buy

TickerLandia Fingerprint: WuXi XDC Cayman

Compared with similar companies: very high financial strength.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

WuXi XDC Cayman is pricier than similar companies

WuXi XDC Cayman's P/E (trailing 12 months): 46.6, +47% against the median of a group of 10 similar companies (31.8).

Compared with 10 similar companies

WuXi XDC Cayman's metrics compared with similar companies
MetricWuXi XDC CaymanPosition in the groupBand
P/E (trailing 12 months)46.6Middle
Forward P/E23.5Middle
Operating margin28.1%High
ROE16.3%Middle
Debt/equity0.05Low

Grey band: the middle half of the group; tick: the median; dot: WuXi XDC Cayman. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥3.7B

Latest quarter · Q2 2026

Net income

¥819.28M

Latest quarter · Q2 2026

Quarterly net margin

22.1%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$75.6B
P/E
46.6
EPS
$1.28
Volume
6.32M
Daily trading
€39.77M
Dividend yield
0.00%

How WuXi XDC Cayman is changing

All results
  • Revenue grew 128.1% a year on average over the last 5 years

  • Operating margin rose from 12.7% to 27.3%

  • Less cash than profit: free cash flow equal to -16% of net income

Returns

WuXi XDC Cayman returns

$1,000 invested in WuXi XDC Cayman 3 years ago, on November 20, 2023, would be worth $2,132 today: +113.21% in total, +28.70% per year. This is the price return only: dividends are excluded.

PeriodWuXi XDC CaymanHang Seng$1,000 becomes
1 month−21.29%−6.10%$787
6 months+3.47%−12.63%$1,035
Year to date−1.65%−12.56%$984
1 year−13.60%−13.26%$864
3 years+113.21%+26.06%$2,132

Over the last 6 months it has done better than 83% of the stocks in the Industrials sector.

Price only, without dividends. Calculate your investment

The chart in detail

WuXi XDC Cayman: technical analysis

WuXi XDC Cayman shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 29.8% below its all-time closing high ($85.10, October 3, 2025).

Trend
No clear trend
RSI (14 sessions)
29
Below 30: a strong fall in a short time
vs 200-session average
−5.16%

Active signals

  • Close below the low of the previous 55 sessions.

  • RSI below 30: the stock has fallen a lot in a short time.

Support and resistance

Price areas where WuXi XDC Cayman has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$69.00+15.58%3 touches, last on September 11, 2026
  2. Resistance$65.84+10.28%4 touches, last on August 10, 2026
  3. Resistance$61.58+3.15%5 touches, last on November 3, 2026
  4. Last price$59.70
  5. Support$58.35−2.26%2 touches, last on May 20, 2026
  6. Support$55.53−6.99%2 touches, last on April 24, 2026
  7. Support$52.00−12.90%2 touches, last on July 17, 2026

Volatility and risk

Over the last year it has moved roughly in line with the Hang Seng.

Beta (1 year) vs Hang Seng
1.17
Volatility (60 sessions, annualised)
50.5%
Largest fall in the last year
−39.49%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

WuXi XDC Cayman and its competitors

Operating in China, North America, Europe and other international markets, WuXi XDC Cayman Inc. provides contract research, development and manufacturing services. Its work covers the discovery, development and production of drug substances and drug products built on antibody-drug conjugates, bioconjugates and monoclonal antibody intermediates, along with payload-linker components. The company also develops and markets anti-tumor drugs and offers international sales contracting services. It has a strategic collaboration with Earendil Labs and with Akari Therapeutics.

Headquarters
Wuxi, China
Employees
3,628
Founded
2013
Chief executive
Jincai Li
WuXi XDC Cayman and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
WuXi XDC Cayman2268$9.64B28.1%46.6+3.47%
Sonic HealthcareSHL$7.13B9.3%17.6+17.41%
WuXi AppTec603259$63.99B44.8%15.7+36.57%
QiagenQIA$10.23B26.7%28.5+50.69%
bioMérieuxBIM$11.82B16.0%23.4+25.67%
ICON PublicICLR$13.99B2.7%74.7+62.23%

Same industry or related industries, similar size. Compare WuXi XDC Cayman with its competitors · Full profile